NIH-funded research R01 grant

Understanding the genetic factors behind chronic low back pain

Official title: Epigenetic Drivers of Chronic Low Back Pain

Funded at University of Minnesota · NIH-10978456 · Data updated 2026-11-12

This study is looking at how changes in your genes might be linked to chronic low back pain from disc problems, and it’s for people who experience this kind of pain; by sharing some samples and information, you can help researchers find new ways to ease your pain and improve your life.

More Low Back Pain research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Minnesota
NIH-funded
Lab location1 site (Minneapolis, United States)
Project startSeptember 3, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$658,385
NIH project number1R01AR083365-01A1
Project IDNIH-10978456 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals suffering from chronic low back pain, particularly those with discogenic pain linked to intervertebral disc degeneration.

Less likely to help

Patients with acute back pain or those whose pain is not related to intervertebral disc degeneration may not benefit from this research.

What this research studies

This research investigates how changes in gene expression, specifically through a process called DNA methylation, contribute to chronic low back pain (LBP) caused by intervertebral disc degeneration. By examining the epigenetic mechanisms involved, the study aims to uncover the biological processes that lead to pain and disability in affected individuals. Patients may be asked to provide biological samples and participate in assessments to help researchers understand the relationship between their pain and genetic factors. The ultimate goal is to identify new treatment targets that could alleviate chronic pain and improve quality of life.

Why it matters

Potential benefit: If successful, this research could lead to new, more effective treatments for chronic low back pain, reducing reliance on opioids and improving patient outcomes.

How similar studies have gone: While the specific focus on DNA methylation in discogenic low back pain is relatively novel, previous research has shown that epigenetic mechanisms can play a significant role in chronic pain conditions.

Where this research is happening

  • University of Minnesota
    Minneapolis, United States
    Active

Researchers

  • Principal investigator: Stone, Laura S — University of Minnesota
  • Study coordinator: Stone, Laura S

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.